Please login to the form below

Not currently logged in

Alliance Pharma's profit up 17 per cent

Alliance Pharma has recorded a net profit increase of 17 per cent for the first half of 2011, with sales up 4 per cent

Alliance Pharma has recorded a net profit increase of 17 per cent for the first half of 2011.

The speciality pharmaceutical company made a pre-tax profit of £7m for the period compared to £6m for the first half of 2010.

Sales were also up, increasing by 4 per cent from £23.4m for the first half of 2010 to £24.4m for the same period of 2011.

The company also announced the acquisition of UK marketing rights to six products from Beacon Pharmaceuticals for £2.4m. The products include acne treatment Rizuderm (isotretinoin).

The move follows previous acquisitions for Alliance this year, including the pain relief therapy Anbesol (benzocaine).

Michael Gatenby, chairman of Alliance Pharma, said: "We are delighted with the two earnings-enhancing acquisitions announced so far this year and continue to assess further opportunities."

7th September 2011


Featured jobs

Subscribe to our email news alerts


Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....